SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001558370-21-012601
Filing Date
2021-09-17
Accepted
2021-09-17 17:00:30
Documents
5
Period of Report
2021-11-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A tmb-20211124xpre14a.htm PRE 14A 160456
2 GRAPHIC tmb-20211124xpre14a013.jpg GRAPHIC 69827
3 GRAPHIC tmb-20211124xpre14a012.jpg GRAPHIC 56354
4 GRAPHIC tmb-20211124xpre14a004.jpg GRAPHIC 15078
5 GRAPHIC tmb-20211124xpre14a003.jpg GRAPHIC 8711
  Complete submission text file 0001558370-21-012601.txt   368850
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 211261134
SIC: 2836 Biological Products, (No Diagnostic Substances)